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jo u rn al ho m epag e: ww w.els evier . c om / lo cat e/ jcc as eCardiac tumors are rare and the incidence of primary tumors
have been reported from 0.0017% to 0.19% in autopsy studies.
Myxoma is the most frequent cardiac tumor, representing about
50% of all benign neoplasms of the heart. In more than 90% of
patients, myxoma was diagnosed incidentally [1]. A minority of
patients showed speciﬁc syndromes (so called Carney complex).
Carney syndrome is characterized by speciﬁc clinical manifesta-
tions, such as myxomas in other sites (e.g. cutaneous, mucosal,
breast), cutaneous lentiginosis, acromegaly, Cushing syndrome
(primary pigmented nodular adrenocortical disease), large-cell
calcifying, Sertoli-cell tumors of the testis, and psammomatous
melanotic schwannoma [2].
Although cardiac myxoma can be found in a wide age range, it is
clearly more common among adults, who present at an average age
of 50 years; furthermore, nonsyndromic cardiac myxomas occur
more commonly in women than in men [3].
The mechanism for neoplastic transformation of cardiac
myxoma is still unclear. Although genetic factors clearly play a
role in myxoma formation, they do not appear to offer a consistent
explanation in sporadic cases. A study by Li et al. reported ﬁnding
evidence for herpes simplex virus type 1 infection in 70% of
a relatively small cohort (n = 17) of surgically resected sporadic
cardiac myxomas [4]. Regardless of the precise etiology of cardiac
myxoma, morphologic, ultrastructural, and immunoperoxidase
studies suggest that the neoplastic cells are of primitive
multipotential mesenchymal origin [5]. Most myxomas (75%)
are located in the left atrium. Most of the remainder (18%) is found
in the right atrium. These tumors are typically found in the region
of the fossa ovalis [5].
The case report in the current issue demonstrated cardiac
myxoma at the left interatrial septum after atrial ﬂutter (AFL)
ablation [6]. Interestingly, cardiac myxoma already has been
reported to develop after catheter ablation in 6 case reports [6]. The
time to diagnosis of myxoma after ablation ranged from 3 months
to 6 years. These case reports raised interesting questions, ‘‘the
etiology of myxoma was radiogenic or not?’’DOI of original article: http://dx.doi.org/10.1016/j.jccase.2015.01.001
http://dx.doi.org/10.1016/j.jccase.2015.04.001
1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightIn the current case report, myxoma was detected at the left
septum 6 months after radiofrequency ablation for cavo-tricuspid
isthmus dependent AFL, so called common AFL. The cavo-tricuspid
isthmus dependent AFL was the most common macro-reentrant
tachycardia of right atrium. The bidirectional block of cavo-
tricuspid isthmus is achieved by radiofrequency applications in
most cases, resulting in more than 90% of patients maintaining
sinus rhythm during long-term follow-up. This procedure usually
does not require a trans-septal approach. Therefore, radio-
frequency delivery and the mechanical trauma appear to be
unrelated to the development of cardiac myxoma of left-
sided atrial septum in this case. The locations of myxoma and
ablation sites were not correspondent in 3 of 6 published case
reports [6].
The ionizing radiation poses increased cancer risks. Roguin et al.
reported that brain cancer develops especially in left brain of
physicians performing interventional procedures. The left side of
the head is known to be more exposed to radiation than the right
[7]. The relation between internal radiation exposure and cancer
risk are not known in the patients undergoing interventional
procedures. The procedure time and ﬂuoroscopic time were not
available in this report, but catheter ablation was usually
completed with ﬂuoroscopic time of less than 30 min in AFL
patients. On the other hand, AF ablation requires trans-septal
approach and longer ﬂuoroscopic time compared to AFL ablation.
Recently the number of AF ablations was increasing all over the
world. However, cardiac myxoma developing after AF ablation
is also rare. These phenomena suggest that this myxoma was
most likely an incidental tumor, which just accidentally occurred
after ablation. However, further investigation for the risk of
radiogenic-induced cancer is required.
Regardless of the mechanism of the tumor development, this
report also indicated the rapid growth rate of cardiac myxoma.
Before the ablation, no tumor was detected by thoracic heart
ultrasonography. Surprisingly, the dimension of the tumor was
about 2.7 cm  4 cm in four-chamber apical view 6 months later.
The growth rate was calculated as more than 0.66 cm/month.
Cardiac myxoma is a relatively rare cardiac tumor and diagnosed
as developed tumor incidentally. Therefore, this case reports reserved.
Editorial / Journal of Cardiology Cases 12 (2015) 30–31 31showed invaluable observation in the oncogenesis of cardiac
myxoma.
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